Leggi il settimanale
Cerca
Edicola digitale
+

Danish Medicines Council Grants Approval for CSL Behring's Respreeza as Standard Treatment for Severe Alpha-1 Antitrypsin Deficiency Patients

default_image

AdnKronos
  • a
  • a
  • a

Dai blog